FAQs
Q1. How does Azelaic Acid in Aziclear Serum treat both acne and pigmentation — can one ingredient really do both?
A1. Azelaic Acid is one of the few dermatological actives with clinically confirmed dual action: it inhibits tyrosinase (the enzyme initiating melanin synthesis), directly reducing hyperpigmentation and post-acne marks; and it inhibits C. acnes bacterial growth while reducing the keratinocyte hyperproliferation that causes comedones. It also has meaningful anti-inflammatory properties, which is why it is one of only three topically approved treatments for rosacea. At a 15–20% concentration used in clinical settings, it outperforms many single-mechanism brightening agents. This multiplex mechanism is why Aziclear's formulation leads with Azelaic Acid for both acne management and pigmentation — particularly relevant for the PIH (post-inflammatory hyperpigmentation) that follows acne in Indian skin tones.
Q2. What does Hydroxyphenoxy Propionic Acid (HPPA) contribute to Aziclear Serum — why include a fourth brightening agent?
A2. Hydroxyphenoxy Propionic Acid is a linoleic acid derivative that acts as a competitive inhibitor of tyrosinase — it competes with L-DOPA for the active site of the enzyme, blocking melanin synthesis through a different binding mechanism than Azelaic Acid uses. This means even if one pathway develops partial resistance, the other continues to work. HPPA is particularly effective at the epidermal-dermal junction where melanosomes are transferred from melanocytes to keratinocytes. Used alongside Resorcinol (which disrupts melanin aggregates in existing pigmented cells) and Ferulic Acid (which scavenges the UV-induced radicals that trigger melanocytes), Aziclear's brightening effect is multi-layered rather than single-mechanism.
Q3. Can Aziclear Serum be used as post-procedure care after chemical peels, laser, or microneedling?
A3. Yes — this is one of Aziclear's documented use cases. After ablative procedures, the skin experiences a temporary inflammatory surge that, in Fitzpatrick types III–VI (most Indian skin tones), can trigger post-procedure PIH. Azelaic Acid and HPPA reduce this post-inflammatory melanocyte activation while the skin heals. Calendula Extract and Aloe Vera in the formula provide soothing and anti-inflammatory support for the compromised barrier. Always confirm with your dermatologist when to introduce an active serum post-procedure — timing varies by procedure type and depth.
Q4. Is it safe to use Aziclear Serum with Vitamin C or Niacinamide serums in the same routine?
A4. Ferulic Acid in Aziclear Serum is frequently combined with Vitamin C in professional formulations to enhance antioxidant potency, so Vitamin C serums are generally compatible and can be synergistic. Niacinamide is also compatible with Azelaic Acid and does not cause the flushing sometimes attributed to niacin. A sensible approach: apply Aziclear Serum on cleansed skin in the evening, allow it to absorb, and use Vitamin C as part of your morning routine. Avoid combining with high-strength AHA or BHA leave-on exfoliants at the same time, as this can irritate an already-active skin surface.
Q5. How quickly will Aziclear Serum fade post-acne dark spots — what should realistic expectations look like?
A5. Post-acne PIH in dark skin tones sits deeper in the epidermis and often extends into the superficial dermis, which is why it takes longer to resolve than it does in lighter skin. With consistent use of Aziclear Serum combined with daily broad-spectrum SPF, surface PIH can show measurable lightening in 6–8 weeks and significant improvement in 12–16 weeks. Deeper dermal PIH may require 6 months or longer. The most common mistake is stopping the serum once surface improvement is visible — PIH often persists at deeper levels and will resurface without continued treatment. Consistency and sun protection are more important than any individual ingredient.
